These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 32167688

  • 1. [Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.].
    Senyuta NB, Smirnova KV, Kondratova VN, Ignatova AV, Mudunov AM, Dushenkina TE, Liechtenstein AV, Gurtsevich VE.
    Vopr Virusol; 2019; 64(5):229-237. PubMed ID: 32167688
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diagnostic value of the Epstein-Barr virus serological markers in patients with nasopharyngeal carcinoma in cases of undetectable primary tumor location.
    Gurtsevitch VE, Senyuta NB, Lomaya MV, Ignatova AV, Dushenkina TE, Repkina IA, Pavlovskaya AI, Mudunov AM.
    Vopr Virusol; 2016; 61(5):205-12. PubMed ID: 29323852
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J, Cui Z, Zheng Y, Li X, Chen Y.
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [Abstract] [Full Text] [Related]

  • 6. Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
    Chen WJ, Xu WN, Wang HY, Chen XX, Li XQ, Xie SH, Lin DF, Cao SM.
    BMC Cancer; 2021 Jun 01; 21(1):651. PubMed ID: 34074258
    [Abstract] [Full Text] [Related]

  • 7. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
    Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Paramita DK, Fachiroh J, Adham M, Tan IB, Haryana SM, Middeldorp JM.
    Int J Cancer; 2006 Aug 01; 119(3):608-14. PubMed ID: 16572427
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Epstein-Barr virus (Herpesviridae: Lymphocryptovirus) types 1 and 2 and other viral markers in patients with nasopharyngeal carcinoma in two geographically and ethnically distinct regions of Russia].
    Smirnova KV, Lubenskaya AK, Senyuta NB, Dushenkina TE, Gurtsevitch VE.
    Vopr Virusol; 2023 Sep 21; 68(4):291-301. PubMed ID: 38156586
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
    Ji MF, Huang QH, Yu X, Liu Z, Li X, Zhang LF, Wang P, Xie SH, Rao HL, Fang F, Guo X, Liu Q, Hong MH, Ye W, Zeng YX, Cao SM.
    Cancer; 2014 May 01; 120(9):1353-60. PubMed ID: 24477877
    [Abstract] [Full Text] [Related]

  • 14. Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
    Zhang WR, Du YY, Guo CY, Zhou HX, Lin JY, Meng XH, Mo HY, Luo DH.
    Cancer Res Treat; 2021 Oct 01; 53(4):991-1003. PubMed ID: 33494127
    [Abstract] [Full Text] [Related]

  • 15. [Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma].
    Luo YL, Chen H, Peng SG, Lin JH, Huang PY.
    Zhonghua Yi Xue Za Zhi; 2013 Nov 26; 93(44):3516-9. PubMed ID: 24521892
    [Abstract] [Full Text] [Related]

  • 16. The serological diagnostic value of EBV-related IgA antibody panels for nasopharyngeal carcinoma: a diagnostic test accuracy meta-analysis.
    Liu H, Lei L, Song S, Geng X, Lin K, Li N, Chen W, Peng J, Ren J.
    BMC Cancer; 2024 Sep 07; 24(1):1115. PubMed ID: 39244576
    [Abstract] [Full Text] [Related]

  • 17. Associations between environmental factors and serological Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma in South China.
    Zhou T, Yang DW, He YQ, Xue WQ, Liao Y, Zheng MQ, Jia YJ, Yuan LL, Zhang WL, Zeng YX, Jia WH.
    Cancer Med; 2019 Aug 07; 8(10):4852-4866. PubMed ID: 31241250
    [Abstract] [Full Text] [Related]

  • 18. Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia.
    Baizig NM, Morand P, Seigneurin JM, Boussen H, Fourati A, Gritli S, Oueslati Z, Touati S, Gamoudi A, Ben Abdallah M, El May M, El May A.
    Eur Arch Otorhinolaryngol; 2012 Mar 07; 269(3):1005-11. PubMed ID: 21805179
    [Abstract] [Full Text] [Related]

  • 19. Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
    Xue N, Lin JH, Xing S, Liu D, Li SB, Lai YZ, Wang XP, Mao MJ, Zhong Q, Zeng MS, Liu WL.
    Cancer Res Treat; 2019 Jan 07; 51(1):378-390. PubMed ID: 29807404
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: A Brief Review.
    Xue F, He X.
    Methods Mol Biol; 2020 Jan 07; 2204():99-107. PubMed ID: 32710318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.